Logo of Robert Koch InstituteLogo of Robert Koch Institute
Publication Server of Robert Koch Instituteedoc
de|en
Browsing Artikel in Fachzeitschriften by Author 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Browsing Artikel in Fachzeitschriften by Author
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Browsing Artikel in Fachzeitschriften by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CommunityTitleAuthorSubject
PublishLoginRegisterHelp
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CommunityTitleAuthorSubject
PublishLoginRegisterHelp
Browsing Artikel in Fachzeitschriften by Author 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Browsing Artikel in Fachzeitschriften by Author
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Browsing Artikel in Fachzeitschriften by Author

Browsing Artikel in Fachzeitschriften by Author "Dahms, Karolina"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Sort by:

Order:

Results:

Now showing items 1-2 of 2

  • title
  • issue date
  • submit date
  • ascending
  • descending
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • 2023-02-25Rezension
      Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis 
      Dahms, Karolina; Mikolajewska, Agata; Ansems, Kelly; Metzendorf, Maria-Inti; Benstoem, Carina; Stegemann, Miriam
      Background At the end of 2021, the European Medicines Agency (EMA) expanded its approval for the recombinant human interleukin‑1 (IL‑1) receptor antagonist Anakinra for the treatment of COVID‑19 patients with elevated ...
    • 2023-02-25Zeitschriftenartikel
      Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis 
      Dahms, Karolina; Mikolajewska, Agata; Ansems, Kelly; Metzendorf, Maria-Inti; Benstoem, Carina; Stegemann, Miriam
      Background: At the end of 2021, the European Medicines Agency (EMA) expanded its approval for the recombinant human interleukin-1 (IL-1) receptor antagonist Anakinra for the treatment of COVID-19 patients with elevated ...
      Terms of Use Imprint Policy Data Privacy Statement Contact

      The Robert Koch Institute is a Federal Institute

      within the portfolio of the Federal Ministry of Health

      © Robert Koch Institute

      All rights reserved unless explicitly granted.